Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9935 USD | -5.38% | -12.85% | +14.86% |
05-08 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
05-08 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.86% | 124M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- KPTI Stock
- News Karyopharm Therapeutics Inc.
- HC Wainwright Adjusts Karyopharm Therapeutics' Price Target to $22 from $23, Keeps Buy Rating